Welcome and thank you for considering the New England Journal of Medicine (NEJM) as a venue for your work. As the oldest continuously-published medical journal, our mission since 1812 has been to ...

In this week’s edition of InnovationRx, we look at the dangers of RFK Jr.’s vaccine advisory committee, how Trump’s visa ban ...

“Print ain’t dead,” claims Rogge. In fact, the North Lake Tahoe owner/publisher/editor believes in it to the extent that he ...

Farzad Mostashari, M.D., ScM, and Geoffrey Moore, Ph.D., authored an article in The New England Journal of Medicine entitled ...

CME activities, cases, challenges, videos, and more teaching and learning tools from the New England Journal of Medicine. Skip to main content. The New England Journal of Medicine NEJM; ...

Each week more than 60 manuscripts arrive at our editorial offices for consideration for publication in the Journal. Our job is to determine which of them are most likely to influence clinical prac ...

One of the more difficult decisions for patients with poorly controlled type 2 diabetes, as well as for their clinicians, is ...

A 62-year-old woman presented with a 1-day history of chest pain on the left side that had radiated to her shoulder and back and was associated with dyspnea, diaphoresis, and lightheadedness.

Limited evidence exists to support the simultaneous initiation of sodium–glucose cotransporter-2 inhibitors and finerenone, a nonsteroidal mineralocorticoid receptor antagonist, in persons with ...

New data from NHANES encouraged the World Health Organization (WHO) to update its screening recommendations for iron-deficiency anemia, and in 2001 the WHO recommended that “for populations of ...

Tarlatamab, a bispecific delta-like ligand 3–directed T-cell engager immunotherapy, received accelerated approval for the treatment of patients with previously treated small-cell lung cancer.